Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?

Therapeutic lymphadenectomy (TLND) is still performed in most melanoma patients to treat nodal recurrences after initial negative lymph node biopsy (-SLNB), despite the lack of evidence for survival benefit. We sought to compare melanoma-specific survival (MSS) and distant metastasis-free survival (DMFS) of patients who underwent TLND versus no TLND using our institutional and MSTL-1 databases.

Source: American Journal of Surgery - October 17, 2023 Category: Surgery Authors: Ana K. Wilson, Kristel Lourdault, Tara Ostad, Stacey Stern, Richard Essner Tags: Original Research Article Source Type: research